Overview

Ketamine for Treatment Resistant MDD

Status:
Unknown status

Trial end date:
2020-12-30

Target enrollment:

Participant gender:

Summary

This study aims to openly test the long-term safety, tolerability and effectiveness of repeated administration of IM/SC ketamine for treatment resistant MDD.

Phase:

N/A

Details

Lead Sponsor:

Hadassah Medical Organization

Treatments:

Ketamine